JP Morgan Chase’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,200
| Closed | -$696 | – | 7878 |
|
|
2024
Q3 | $696 | Buy |
1,200
+364
| +44% | +$204 | ﹤0.01% | 6766 |
|
|
2024
Q2 | $517 | Sell |
836
-34,532
| -98% | -$29.2K | ﹤0.01% | 6686 |
|
|
2024
Q1 | $90.9K | Sell |
35,368
-27,806
| -44% | -$67.9K | ﹤0.01% | 5709 |
|
|
2023
Q4 | $129K | Sell |
63,174
-11,241
| -15% | -$20.5K | ﹤0.01% | 5615 |
|
|
2023
Q3 | $128K | Buy |
74,415
+3,288
| +5% | +$5.84K | ﹤0.01% | 5335 |
|
|
2023
Q2 | $139K | Buy |
71,127
+35,951
| +102% | +$84.2K | ﹤0.01% | 5295 |
|
|
2023
Q1 | $97K | Buy |
35,176
+5,255
| +18% | +$15K | ﹤0.01% | 5444 |
|
|
2022
Q4 | $103K | Buy |
29,921
+25,138
| +526% | +$71.8K | ﹤0.01% | 5348 |
|
|
2022
Q3 | $12K | Buy |
4,783
+1,994
| +71% | +$6.35K | ﹤0.01% | 5935 |
|
|
2022
Q2 | $7K | Sell |
2,789
-63,351
| -96% | -$166K | ﹤0.01% | 6110 |
|
|
2022
Q1 | $273K | Buy |
66,140
+4,557
| +7% | +$24.1K | ﹤0.01% | 5021 |
|
|
2021
Q4 | $792K | Sell |
61,583
-57,648
| -48% | -$638K | ﹤0.01% | 4550 |
|
|
2021
Q3 | $1.29M | Buy |
119,231
+10,526
| +10% | +$95.8K | ﹤0.01% | 4120 |
|
|
2021
Q2 | $993K | Sell |
108,705
-266,076
| -71% | -$2.46M | ﹤0.01% | 4301 |
|
|
2021
Q1 | $3.53M | Buy |
374,781
+201,965
| +117% | +$2.78M | ﹤0.01% | 3266 |
|
|
2020
Q4 | $681K | Sell |
172,816
-4,799
| -3% | -$14.5K | ﹤0.01% | 4190 |
|
|
2020
Q3 | $470K | Sell |
177,615
-129,363
| -42% | -$480K | ﹤0.01% | 4016 |
|
|
2020
Q2 | $2.04M | Buy |
306,978
+165,092
| +116% | +$1.11M | ﹤0.01% | 3094 |
|
|
2020
Q1 | $825K | Buy |
141,886
+9,965
| +8% | +$83.7K | ﹤0.01% | 3530 |
|
|
2019
Q4 | $1.18M | Buy |
131,921
+6,451
| +5% | +$53.8K | ﹤0.01% | 3738 |
|
|
2019
Q3 | $1.08M | Buy |
125,470
+4,875
| +4% | +$49.3K | ﹤0.01% | 3791 |
|
|
2019
Q2 | $1.2M | Buy |
120,595
+1,507
| +1% | +$17.2K | ﹤0.01% | 3738 |
|
|
2019
Q1 | $1.58M | Sell |
119,088
-4,280
| -3% | -$57.2K | ﹤0.01% | 3502 |
|
|
2018
Q4 | $1.91M | Sell |
123,368
-21,632
| -15% | -$413K | ﹤0.01% | 3314 |
|
|
2018
Q3 | $2.06M | Buy |
+145,000
| New | +$2.06M | ﹤0.01% | 3448 |
|
Other funds holding GRTS
JP Morgan Chase's GRTS Position: Q4 2024 in Review
JP Morgan Chase sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 1,200 shares — an estimated $696 sold.
JP Morgan Chase first reported a position in GRTS in Q3 2018 and held it in 25 quarters. The position peaked at $3.53M in Q1 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.
- JP Morgan Chase reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- JP Morgan Chase sold 1,200 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $696.
- JP Morgan Chase first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 25 quarters.
- JP Morgan Chase's Gritstone bio, Inc. Common Stock position peaked at $3.53M in Q1 2021.
- 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.